UPDATE : Monday, September 7, 2020
상단여백
Roche to test Tecentriq to expand indication to breast cancer
Roche Korea said it would conduct a clinical trial on immunotherapy Tecentr...
by Lee Hye-seon  |  2017-11-21 15:30
라인
Menarini’s painkiller Abstral faces competition with generics
BC World Pharm has won approval to sell Narco Sublingual 100㎍, the first ge...
by Lee Hye-seon  |  2017-11-17 20:44
라인
GSK to test combo of 2 anti-HIV drugs
GlaxoSmithKline will start a clinical trial on a combination of long-acting...
by Lee Hye-seon  |  2017-11-16 11:27
라인
Will new research calm controversies over heat-not-burn cigarettes?
Amid controversies over the danger of electronic cigarettes, Philip Morris ...
by Lee Hye-seon  |  2017-11-15 13:12
라인
Celltrion to test combo therapy of new flu antibody drug, Tamiflu
Celltrion said it plans to launch a clinical trial on a combination therapy...
by Lee Hye-seon  |  2017-11-14 11:38
라인
Sanofi gets approval to sell diabetes combo Soliqua in Korea
Sanofi-Aventis Korea, a local unit of French drug giant Sanofi, said it rec...
by Lee Hye-seon  |  2017-11-10 13:03
라인
Illegal abortive drug circulates online amid safety concerns
With a debate intensifying over the legalization of abortion in Korea, some...
by Lee Hye-seon  |  2017-11-09 14:44
라인
BMI Korea faces 3-month sales ban on HiDr for unauthorized ad
The Ministry of Food and Drug Safety has slapped BMI Korea a three-month ba...
by Lee Hye-seon  |  2017-11-07 15:47
라인
New adverse reactions added to linezolid, idarubicin-based drugs
South Korea’s health authorities said they plan to add newly reported adver...
by Lee Hye-seon  |  2017-11-07 15:04
라인
Allergan nixes contract with Dong-A ST over evogliptin license
Allergan has nullified its contract with Dong-A ST over the exclusive right...
by Lee Hye-seon  |  2017-11-02 13:59
라인
Drugmakers see robust earnings in Q3
Yuhan Corp. and Green Cross, Korea’s two largest pharmaceutical firms by sa...
by Lee Hye-seon  |  2017-11-01 13:19
라인
Drugmakers brace for possible renegotiation of Korea-US FTA
Korean drugmakers and biopharma manufacturers are bracing for possible chan...
by Lee Hye-seon  |  2017-10-31 16:38
라인
Myongji Hospital chairman becomes MGmed’s largest shareholder
Lee Wang-jun, chairman of Myongji Hospital’s board of directors and chairma...
by Lee Hye-seon  |  2017-10-31 13:26
라인
Gilead to encourage switching to Vemlidy with new test
Gilead, which developed new drug Vemlidy (ingredient: tenofovir ala fenamid...
by Lee Hye-seon  |  2017-10-30 13:10
라인
Dizziness, headache added to precautions for Lixiana
Anti-blood clotting drug Lixiana (ingredient: edoxaban), manufactured by Da...
by Lee Hye-seon  |  2017-10-25 17:50
라인
Drugmakers to adopt anti-bribery management system ‘ISO 37001’
Korean drugmakers have announced that they would introduce an international...
by Lee Hye-seon  |  2017-10-24 15:59
라인
Korean pharmaceuticals vie to preempt dry eye treatment market
Korean pharmaceutical companies are striving to develop new drugs to treat ...
by Lee Hye-seon  |  2017-10-23 15:31
라인
Bullous pemphigoid added to precautions for DPP-4 inhibitors
Antidiabetic drugs of dipeptidyl peptidase-4 (DPP-4) inhibitor series will ...
by Lee Hye-seon  |  2017-10-20 16:02
라인
‘Hepatitis C should be part of national health check’
A recent survey found that a majority of doctors specializing in liver dise...
by Lee Hye-seon  |  2017-10-19 16:57
라인
‘Poziotinib effective for rare non-small-cell lung cancer’
Patients with rare EGFR exon 20 mutation, accounting for about 10 percent o...
by Lee Hye-seon  |  2017-10-18 15:45
-이전11121314-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top